Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review S. J. GallacherT. Dixon REVIEW 26 September 2010 Pages: 469 - 484
Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis Julie SatterwhiteMichael HeathmanHarald Dobnig OriginalPaper Open access 16 October 2010 Pages: 485 - 492
Normative Calcaneal Quantitative Ultrasound Data as an Estimation of Skeletal Development in Swedish Children and Adolescents Gayani AlwisBjörn RosengrenMagnus K. Karlsson OriginalPaper 20 October 2010 Pages: 493 - 506
Lipid Profiles and Bone Mineral Density in Pre- and Postmenopausal Women in Korea In-Kyong JeongSun Wook ChoChan Soo Shin OriginalPaper 27 October 2010 Pages: 507 - 512
Osteogenic Potential of Biosilica on Human Osteoblast-Like (SaOS-2) Cells Matthias WiensXiaohong WangWerner E. G. Müller OriginalPaper 20 August 2010 Pages: 513 - 524
The Biphenyl-Carboxylate Derivative ABD328 is a Novel Orally Active Antiresorptive Agent Aymen I. IdrisEmmanuel CosteRob J. van’t Hof OriginalPaper 18 September 2010 Pages: 525 - 532
Integration of Phosphatidylinositol 3-Kinase, Akt Kinase, and Smad Signaling Pathway in BMP-2-Induced Osterix Expression Chandi Charan MandalHicham DrissiNandini Ghosh-Choudhury OriginalPaper 26 September 2010 Pages: 533 - 540
Muscle Changes Can Account for Bone Loss After Botulinum Toxin Injection Sarah L. ManskeSteven K. BoydRonald F. Zernicke OriginalPaper 22 October 2010 Pages: 541 - 549
Erratum to: Risk of Upper Gastrointestinal Tract Events in Risedronate Users Switched to Alendronate Stuart H. RalstonTzuyung D. KouTahir Masud Erratum 24 October 2010 Pages: 550 - 550
